A federal judge has rejected Santa Clara County, California’s bid to have its case against GlaxoSmithKline over Avandia removed from the federal multidistrict litigation over the diabetes drug, but made way for an appellate court to immediately review the decision.
U.S. District Judge Cynthia Rufe of the Eastern District of Pennsylvania ruled that the Philadelphia-based MDL has jurisdiction over the case, which was filed in 2010 over claims that the company “bilked” purchasers of the diabetes drug. Hoping for a finding that there was no federal jurisdiction, the plaintiff was seeking to have the case sent to state court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
